The role of metalloprotease-PAR1 signaling in vascular injury and repair

金属蛋白酶-PAR1信号在血管损伤和修复中的作用

• 批准号: 8431468
• 负责人: Karyn Marie Austin
• 金额: $ 3.8万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-02-06 至 2017-02-05
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8431468
• 关键词: Accounting; Acute; Agonist; Americas; Aneurysm; Angioplasty; Arterial Fatty Streak; Atherosclerosis; Blood Vessels; Cardiovascular Diseases; Carotid Arteries; Cause of Death; Cell Proliferation; Cell physiology; Cells; Cessation of life; Characteristics; Chronic; Cleaved cell; Coronary; Coronary Arteriosclerosis; Data; Development; Disease; Endopeptidases; Ethnic group; Event; Extracellular Matrix Degradation; Family; Functional disorder; G Protein-Coupled Receptor Signaling; G-Protein-Coupled Receptors; GTP-Binding Proteins; Goals; In Vitro; Inflammatory; Injury; Intervention; Knockout Mice; Lesion; MAP Kinase Gene; Malignant Neoplasms; Measures; Metabolic; Metalloproteases; Modeling; Molecular; Morbidity - disease rate; Mus; Myocardial Infarction; Nature; Outcome; PAR-1 Receptor; Pathogenesis; Pathologic; Pathology; Pathway interactions; Peptide Hydrolases; Phenotype; Physiological; Physiology; Plasma; Play; Population; Prevention; Process; Production; Proliferating; Property; Publishing; Race; Relative (related person); Research; Role; Rupture; Sepsis; Signal Transduction; Site; Smooth Muscle Myocytes; Source; Stroke; Testing; Therapeutic; Thrombin; Thrombosis; Time; United States; Vascular remodeling; Work; activated Protein C; autocrine; base; cell behavior; design; improved; in vitro Assay; injury and repair; interest; interstitial; migration; mortality; mouse model; neointima formation; pre-clinical; repaired; research study; response; restenosis; theories

DESCRIPTION (provided by applicant): Cardiovascular disease (CVD) is the single leading cause of death in America. The major underlying pathology contributing to CVD is atherosclerosis. The dynamic nature of atherosclerosis involves remodeling of the blood vessel wall to accommodate for changes in vessel compliance. Initially, this process is adaptive, later it becomes injurious. An important component of vascular remodeling includes the phenotypic modulation of smooth muscle cells (SMCs) in and around the atherosclerotic plaque. SMCs undergo dramatic changes following blood vessel injury; cells proliferate, become invasive, and modify their metabolic properties. The molecular mechanisms underlying SMC behavior are poorly understood. An important characteristic of the pathologic SMC phenotype is the production of proteases that allow for SMC invasion and vessel remodeling. Matrix metalloproteases (MMPs) are a family of endopeptidases that are largely responsible for the degradation of extracellular matrix, and play important roles in vascular remodeling and modulation of SMC behavior. MMP1 is a key player in the process of vascular repair, and is often over-expressed in atherosclerotic plaques. Published data show that MMP1 is an important activator of protease-activated receptor 1 (PAR1). SMCs express high levels of PAR1, and expression is increased in atherosclerotic plaques. The role of PAR1 signaling in SMCs represents an interesting paradox in vascular physiology; the cells only contact the natural activator, thrombin, during times of injury, which raises numerous questions about the role of PAR1 on SMCs. Furthermore, MMP1 and thrombin cleave and activate PAR1 at differing sites, leading to the hypothesis that thrombin and MMP1 differentially activate PAR1 to modulate SMC activity following vascular damage. The long-term goal of this project is to better understand the pathophysiology of maladaptive vascular remodeling. The immediate objective is to investigate the mechanism of a thrombin-MMP1-PAR1 signaling axis in vascular repair. To accomplish these goals, two specific aims have been identified. First, to characterize the role of thrombin- vs MMP1-activated PAR1 signaling in vascular repair, and second, explore the contribution of PAR1 signaling in mouse models of vascular injury. To accomplish aim 1, in vitro assays for proliferation, migration, and invasion will be performed on SMCs utilizing PAR1 and MMP1 agonists/antagonists. Furthermore, we will interrogate the mechanism of thrombin- vs MMP1-activated PAR1 in SMCs. Additionally, the role of a thrombin-MMP1-PAR1 autocrine axis will also be explored. Mouse models of vascular repair will be used to investigate aim 2. Carotid artery wire injury will be performed on PAR1 and MMP1 knock-out mice, and vessels will be analyzed for neointimal lesion formation. Finally, the efficacy of PAR1 targeted pepducins will be tested as therapies for the treatment and prevention of vascular neointimal formation.

描述（由申请人提供）：心血管疾病（CVD）是美国唯一的主要死亡原因。导致CVD的主要潜在病理是动脉粥样硬化。动脉粥样硬化的动态性质涉及血管壁的重塑以适应血管顺应性的变化。最初，这个过程是适应性的，后来它 变得有害。血管重塑的一个重要组成部分包括动脉粥样硬化斑块内和周围的平滑肌细胞（SMC）的表型调节。SMC在血管损伤后发生显著变化;细胞增殖，变得具有侵袭性，并改变其代谢特性。SMC行为背后的分子机制知之甚少。病理性SMC表型的一个重要特征是产生允许SMC侵袭和血管重塑的蛋白酶。基质金属蛋白酶（Matrix metalloproteins，MMPs）是一类主要负责细胞外基质降解的内肽酶家族，在血管重塑和SMC行为调节中发挥重要作用。MMP 1是血管修复过程中的关键参与者，并且经常在动脉粥样硬化斑块中过度表达。已发表的数据表明，MMP 1是蛋白酶激活受体1（PAR 1）的重要激活剂。SMC表达高水平的PAR 1，并且在动脉粥样硬化斑块中表达增加。PAR 1信号在SMC中的作用代表了血管生理学中一个有趣的悖论;细胞在损伤期间仅接触天然激活剂凝血酶，这引起了许多关于PAR 1在SMC中作用的问题。此外，MMP 1和凝血酶在不同位点切割和激活PAR 1，导致凝血酶和MMP 1差异激活PAR 1以调节血管损伤后SMC活性的假设。本项目的长期目标是更好地了解 适应不良血管重塑的病理生理学。近期的目标是研究凝血酶-MMP 1-PAR 1信号轴在血管修复中的机制。为实现这些目标，确定了两个具体目标。首先，描述凝血酶激活的PAR 1信号转导与MMP 1激活的PAR 1信号转导在血管修复中的作用，其次，探索PAR 1信号转导在小鼠血管损伤模型中的作用。为了实现目标1，将使用PAR 1和MMP 1激动剂/拮抗剂对SMC进行增殖、迁移和侵袭的体外测定。此外，我们还将探讨凝血酶与MMP 1激活平滑肌细胞中PAR 1的机制。此外，凝血酶-MMP 1-PAR 1自分泌轴的作用也将进行探讨。血管修复的小鼠模型将用于研究目标2。将对PAR 1和MMP 1敲除小鼠进行颈动脉导丝损伤，并分析血管的新生内膜病变形成。最后，将测试PAR 1靶向肽蛋白作为治疗和预防血管新生内膜形成的疗法的功效。